In 2017, Eagle Pharma got a tentative FDA green light for its version of the drug, which it plans to sell as Pemfexy once Lilly’s exclusivity for its brand runs out. Sage Therapeutics has ...
On October 3, 2024, Union Square Park Capital Management, LLC (Trades, Portfolio) made a significant move in the pharmaceutical sector by acquiring 1,191,490 shares of Eagle Pharmaceuticals Inc ...
WOODCLIFF LAKE, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company” or “Eagle”) today announced that it received ...